Clover's AI capabilities drive revenue growth and efficiency, setting the stage for future profitability. Read here to know ...

Health insurance company Clover Health (NASDAQ:CLOV) in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was $0.03 above analysts’ consensus estimates.

Q4 2024 Earnings Call Transcript February 27, 2025Clover Health Investments, Corp. beats earnings expectations.

Reports Q4 revenue $$336.96M , consensus $347.41M….”2024 was a pivotal year for us as we demonstrated that our technology-first physician ...

Cellectar Biosciences Inc (CLRB) extends cash runway into late 2025 while navigating regulatory hurdles and exploring new ...

It’s my pleasure to have the team from Clover here. Peter, I think why don’t we just go ahead and get started? We can you got some slides you want to go over and then we can get into some Q and A.

Andrew Toy; Chief Executive Officer, Co-Founder; Clover Health Investments Corp Peter Kuipers; Chief Financial Officer; Clover Health Investments Corp Ladies and gentlemen, good afternoon ...